With the specter of antibiotic-resistant micro organism on the rise, scientists are researching what some would think about being an unconventional answer––Cannabidiol (CBD).

In a recent experiment carried out in a managed atmosphere, Botanix Pharmaceuticals, an Australian biotech analysis agency, demonstrated that CBD can eradicate gram-negative bacteria, a kind of micro organism that has exhibited excessive resistance to antibiotics.

The lead researcher on the undertaking, Dr. Mark Blaskovich of the College of Queensland, reported that of their research, CBD had demonstrated security for human use and believes that the anti-inflammatory properties inside CBD might show to be worthwhile sooner or later analysis of antibiotics.

Insights Revealed by this Analysis

Of their research, Dr. Blaskovich and his workforce discovered that CBD was efficient in killing a number of gram-negative micro organism strains together with Staphylococcus aureus, Streptococcus pneumoniae, and even MRSA, a staph micro organism extremely acknowledged for its resilience to antibiotics.

As well as, the researchers reported that the micro organism have been unable to develop a resistance to CBD, even after twenty-one days of publicity, which is the place most antibiotics fall quick.

In response to the research, CBD had succeeded the place nearly each different antibiotic had failed as a result of it was capable of disrupt the protecting layer of the micro organism often called the biofilm.

In a public assertion issued earlier this month, Dr. Blaskovich remarked that he seems ahead to “presenting this thrilling knowledge on the upcoming ASM Microbe convention in San Francisco.”

The Way forward for CBD Towards Superbug Infections

Whereas the findings revealed on this research are very promising, extra analysis will probably be wanted to find out the effectiveness of CBD in opposition to gram-negative micro organism exterior of a laboratory atmosphere.

If the findings revealed by Dr. Blaskovich’s analysis workforce will be repeated and refined exterior of a laboratory atmosphere, CBD may very well be a robust answer in opposition to superbug infections sooner or later.

Matt Callahan, Executive Director and founder of Botanix said “The implications and potential purposes of those exceptional outcomes are immense.” Botanix has commented that they wish to transfer to medical trials later in 2019.